On May 18, 2006, ali's health disclosed the results of the 2017 fiscal year ending March 31, 2017, with revenue of 475 million yuan, up 739.40 percent year on year. Gross profit was 1887 million yuan, up 392.80 percent year on year. The main reason for the big increase in revenue and gross margin was the rapid growth of the pharmaceutical e-commerce business, the report said. 

 

Alibaba's main health businesses include pharmaceutical e-commerce, drug tracing platform management and smart medical services. Medical electrical business include proprietary medical B2C business to the cat, the main body of "providing outsourcing and value-added services, in distribution and other related business", the wisdom of medical business now is still in its early stage of development, as of March 31, 2017, the cumulative provides clean harem 6 million online medical health counseling. 

 

In the fiscal year 2017, alibaba's revenue was 0.96 billion yuan. Medical electrical business total revenue of 379 million yuan, including medical B2C business revenue of 291 million yuan, to the cat to providing outsourcing and value-added services revenue of 040 million yuan, in the distribution business revenue of 023 million yuan, other business revenue of 025 million yuan. 

 

 

 

The pharmaceutical e-commerce business is the biggest source of revenue for ali 

 

The Tmall medical center, China's largest third-party platform for B2C, has been involved in the B2C business since the second half of 2016. 

 

At the end of May 2016, 95095 merchants (the merchants of Tmall medicine) issued a notice to stop selling pharmaceutical items from May 27, 2017. The reason is to receive a notice from hebei's fda to stop the online retail business of the third-party platform. 

 

Suspended the third-party platform after drug online retail business, ali health through acquisitions have medical electricity C card offline chain pharmacies, proprietary medicine B2C business way, using the model from Tmall medicine pavilion jump to conscience large pharmacy website (now renamed as ali health pharmacy). At the same time, the other businesses in the Tmall medical center have switched to "consumer submission demand, delivery to payment" mode. 

 

On July 6, 2016, ali health announcement, already with guangzhou medicine chain co., LTD., conclude a deal in five thousand, with 16.8 million yuan to buy the company full ownership. The latter obtained the C certificate of the Internet drug trading service certificate issued by guangzhou food and drug administration on January 30, 2015. Later, in five thousand in guangzhou pharmaceutical chain co., LTD renamed ali health pharmacy medicine chain co., LTD., the original conscience big pharmacy is renamed as ali health pharmacy. 

 

Alibaba's B2C business is growing fast. According to its interim results on November 24, 2016, online proprietary-store revenues reached 789, 000 yuan in more than half a month. As of Sept. 30, its B2C pharmacies earned 1.38 million yuan. 

 

The business-to-business B2C business income range from 0 to 291 million yuan, and ali's health took less than nine months. Ali health 2017 earnings is introduced, with the group operation and brand advantage, and the efficient implementation of the team, the group quickly improve the warehousing, logistics, customer service and other supporting system, promoting the fast development of the medical electrical business proprietary. The business has rapidly grown into a major source of revenue for the group at this stage. 

 

According to the results, ali to lead healthy, "Chinese medicine O2O pioneer alliance" has begun to take shape, since May 2016, health and desheng hall, hundred HuiSuHe ali, the thatched cottage, kang love 65 chain drugstores, jointly announced the formation of "Chinese medicine O2O pioneer league", have "with more than 200 chain drugstores, covering the whole of China through the city of more than 20000 pharmacy stores." 

 

It is worth noting that in addition to the B2C business, ali's health has begun to lay out the distribution of pharmaceutical supply chains. Ali health explained that "the Chinese medical care market characteristics of the distribution of health care products is highly fragmented and long supply chain. There are many can promote efficiency of the supply chain of pharmaceutical products space. The group is committed to using the Internet to promote the transparency of medical care products supply chain, improve supply chain efficiency, so that the market participants and consumers can benefit from it." In January 2015, Tmall had obtained A certificate of medical and electronic commerce, according to the national food and drug administration database. Alibaba's business-to-business platform and business are also coming. 

 

Half of China's drug companies are already on the platform 

 

In addition to the pharmaceutical and e-commerce businesses, the drug traceability platform is the second most important business. In the fiscal year 2017, alibaba's revenue from the platform was 0.96 billion yuan, up 70.16 percent. Since 2016, alibaba's health-tracking platform has seen a lot of ups and downs. 

 

By March 31, 2017, at least, including medical application and food industry, tonic, more than 5000 companies signed a contract with the group, in yards on the trust platform, including in the number of pharmaceutical production enterprise has more than half of the total number of pharmaceutical production enterprises in China.